The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions by N. Papini et al.
The Plasma Membrane-associated Sialidase MmNEU3 Modifies the
Ganglioside Pattern of Adjacent Cells Supporting Its Involvement in
Cell-to-Cell Interactions*
Received for publication, January 27, 2004, and in revised form, February 16, 2004
Published, JBC Papers in Press, February 16, 2004, DOI 10.1074/jbc.M400881200
Nadia Papini‡, Luigi Anastasia‡, Cristina Tringali‡, Gianluigi Croci‡, Roberto Bresciani§,
Kazunori Yamaguchi¶, Taeko Miyagi¶, Augusto Preti§, Alessandro Prinetti‡, Simona Prioni‡,
Sandro Sonnino‡, Guido Tettamanti‡, Bruno Venerando‡, and Eugenio Monti§
From the ‡Department of Medical Chemistry, Biochemistry, and Biotechnology, Center of Excellence on Neurodegenerative
Diseases, School of Medicine, University of Milan, 20090 Segrate, Italy, §Department of Biomedical Sciences and
Biotechnology, School of Medicine, University of Brescia, 25123 Brescia, Italy, and ¶Division of Biochemistry, Research
Institute, Miyagi Prefectural Cancer Center, Natori, Miyagi 981-1293, Japan
We describe herein the enzyme behavior of MmNEU3,
the plasma membrane-associated sialidase from mouse
(Mus musculus). MmNEU3 is localized at the plasma
membrane as demonstrated directly by confocal micros-
copy analysis. In addition, administration of the radio-
labeled ganglioside GD1a to MmNEU3-transfected cells,
under conditions that prevent lysosomal activity, led to
its hydrolysis into ganglioside GM1, further indicating
the plasma membrane topology of MmNEU3. Metabolic
labeling with [1-3H]sphingosine allowed the character-
ization of the ganglioside patterns of COS-7 cells.
MmNEU3 expression in COS-7 cells led to an extensive
modification of the cell ganglioside pattern, i.e. GM3 and
GD1a content was decreased to about one-third com-
pared with mock-transfected cells. At the same time, a
35% increase in ganglioside GM1 content was observed.
Mixed culture of MmNEU3-transfected cells with
[1-3H]sphingosine-labeled cells demonstrates that the
enzyme present at the cell surface is able to recognize
gangliosides exposed on the membrane of nearby cells.
Under these experimental conditions, the extent of gan-
glioside pattern changes was a function of MmNEU3
transient expression. Overall, the variations in GM3,
GD1a, and GM1 content were very similar to those ob-
served in the case of [1-3H]sphingosine-labeled
MmNEU3-transfected cells, indicating that the enzyme
mainly exerted its activity toward ganglioside sub-
strates present at the surface of neighboring cells. These
results indicate that the plasma membrane-associated
sialidase MmNEU3 is able to hydrolyze ganglioside sub-
strates in intact living cells at a neutral pH, mainly
through cell-to-cell interactions.
Glycosphingolipids (GSLs)1 expressed at the cell surface are
well known as modulators of several aspects of signal trans-
duction processes involved in the control of cell proliferation,
survival, and differentiation (1). GSLs in the plasma mem-
brane are able to interact laterally with other membrane mol-
ecules modulating their properties (cis-interactions). Lipid
rafts or membrane microdomains result from dynamic cluster-
ing of sphingolipids and cholesterol to form the so-called sphin-
golipid-enriched domain (SED) or lipid rafts (2). These struc-
tures move within the fluid bilayer and function as platforms
for the attachment of proteins when membranes are moved
around the cell and during signal transduction (3, 4). In addi-
tion, the expression pattern of GSLs in several cells and tissues
undergoes deep changes during development and neoplastic
transformation (5). These events are usually characterized by
dramatic changes in cell recognition, suggesting that GSLs as
cell surface antigens could play relevant roles as receptor sites
in cell-cell recognition (trans-interaction). The receptor role of
GSLs has been hypothesized in the case of microbial infections
based on their ability to interact with bacterial toxins and
microbial lectins (6, 7). Conformational analysis confirms that
the orientation of the oligosaccharide chains of glycolipids at
the cell surface complies with the possibility to interact with
extracellular molecules (8, 9). Indeed, synthetic analogues of
GSL oligosaccharides are able to block cell-cell recognition (10).
In the case of mammalian cells, trans-GSL-GSL interactions
are important in determining the motility and metastatic po-
tential of tumor cells (11). For example, in B16 melanoma cells,
characterized by high levels of GM3,2 the adhesion to endothe-
lial cells is a GM3-dependent phenomenon. GM3 is closely
associated with c-Src, Rho, and Ras within SED, and interac-
tions with globoside Gg3 or the use of anti-GM3 antibody
stimulate focal adhesion kinase phosphorylation and c-Src ac-
tivity. In these conditions, not only adhesion but also spreading
and enhancement of cell motility occur (12). Similar results
have been obtained in the case of globoside-dependent adhesion
in human embryonal carcinoma 2102 cells (13).
On the other hand, several different classes of cell surface
proteins potentially can interact with specific carbohydrate
sequences of GSLs, including animal lectins and receptors with
lectin sequence homologies such as selectin family receptors
and human lymphocyte IgE receptor (1). It has been shown
that in the nervous system gangliosides represent functional
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ligands for the myelin-associated glycoprotein, a sialic acid
binding lectin involved in myelin-axon interactions (14). Other
cell surface proteins that are natural candidates for the inter-
action with GSL oligosaccharides are glycosyltransferases and
glycohydrolases. In the past, little attention was paid to these
proteins concerning this aspect, because their main localization
was believed to be restricted inside the cell. Today, increasing
evidence of the presence of such proteins at the level of the
plasma membrane suggests their possible role as a cell recog-
nition site for GSLs. Sialidases or neuraminidases (EC
3.2.1.18) are hydrolytic enzymes that remove sialic acid resi-
dues from gangliosides and other natural substrates. Among
these proteins, plasma membrane-associated sialidase has
been described in different tissues (15–17) and cell types (18–
20), and a form linked to the membrane via glycosylphosphati-
dylinositol anchor has also been identified (21, 22). Evidence of
a possible involvement of this enzyme in the regulation of the
sialic acid levels of the cell surface has been produced. For
example, in neuroblastoma cells the enzyme triggers selective
ganglioside desialylation, and such surface glycolipid modula-
tions are involved in cell growth control and differentiation
(23–25). The plasma membrane sialidase NEU3 3 is character-
ized by high substrate specificity for ganglioside substrates in
the acidic range of pH (26). In addition, MmNEU3 has been
demonstrated to be associated with SED in the neuroblastoma
cell line SK-N-MC (27) as well as in HeLa and COS-1 cells,
where it is closely associated with caveolin (28).
Herein we report the first direct evidence that: (i) MmNEU3
has enzyme activity toward gangliosides in intact living cells;
and (ii) the enzyme activity of MmNEU3 is able to modulate
the expression of gangliosides at the surface of adjacent cells.
EXPERIMENTAL PROCEDURES
Materials—Commercial chemicals were the purest available, com-
mon solvents were distilled before use, and deionized water obtained by
a MilliQ system (Millipore) was distilled in a glass apparatus. High
performance silica gel-precoated thin-layer plates (HPTLC Kieselgel
60, 20  10 cm) were purchased from Merck GmbH.
Sphingosine was prepared from cerebroside (29). [1-3H]Sphingosine
(radiochemical purity 98%, specific radioactivity 2.08 Ci/mmol) was
prepared by specific chemical oxidation of the primary hydroxyl group
of sphingosine followed by reduction with sodium boro[3H]hydride (30).
Ganglioside GD1a was purified from the total ganglioside mixture
extracted from bovine brains (31). Radioactive GD1a containing
erythro-C18-sphingosine, isotopically tritium-labeled at position 3,
[3-3H(Sph18)]GD1a, was prepared by the dichloro-dicyano-benzoqui-
none/sodium boro[3H]hydride method followed by reversed phase HPLC
purification (homogeneity 99%, specific radioactivity of 1.2 Ci/mmol)
(32, 33).
Radioactive sphingolipids were extracted from cells fed with
[1-3H]sphingosine, purified, characterized as described previously (34),
and used as chromatographic standards. Standard molecular biology
techniques were carried out as described by Sambrook and Russell (35).
Tissue Culture and Expression of MmNEU3 in COS-7—COS-7 cells
were grown in Petri dishes (100 mm diameter) using Dulbecco’s modi-
fied Eagle’s medium (DMEM) with 10% (v/v) fetal bovine serum
(Sigma). A sialidase expression plasmid coding for MmNEU3 with a
hemagglutinin (HA) tag at the C terminus was constructed as follows.
The entire open reading frame of the enzyme was amplified with the HA
epitope at the C terminus by PCR using MmNEU3 cDNA in pBluescript
(Stratagene) as template and subcloned into pcDNA1 mammalian ex-
pression vector (Invitrogen), giving rise to the construct pcDNA1-
MmNEU3 (36). The sequence of the construct was confirmed by auto-
mated DNA sequencing. Transfections were performed overnight with
pcDNA1-MmNEU3 construct or with pcDNA1 vector and Lipo-
fectAMINE reagent in accordance with the manufacturer’s guidelines
(Invitrogen) using 4–5  105 cells/dish. Cells were harvested at 48 h
after transfection by scraping, washed in PBS, and resuspended in the
same buffer containing 1 mM EDTA, 1 g/ml pepstatin A, 10 g/ml
apoprotinin, and 10 g/ml leupeptin. Total cell extracts were prepared
by sonication. Lipid extraction and analysis of sphingolipid component
were performed on total cell extracts. The supernatant obtained after
centrifugation at 800  g for 10 min corresponded to the crude cell
extract and was subsequently centrifuged at 200,000  g for 15 min on
an Optima TL 100 Ultracentrifuge (Beckman). Aliquots of the crude cell
extract, 200,000  g supernatant and pellet, were used for assays for
protein (Coomassie Protein Assay Reagent; Pierce) and sialidase activ-
ity, as well as for Western blot analysis. Cell vitality was determined by
the trypan blue procedure.
Treatment of Cell Cultures with [1-3H]Sphingosine—[1-3H]Sphin-
gosine dissolved in methanol was transferred into a sterile glass tube
and dried under a nitrogen stream. The residue was then dissolved in
an appropriate volume of pre-warmed (37 °C) 10% fetal bovine serum
DMEM medium to obtain a final concentration of 3  108 M (corre-
sponding to 0.4 Ci/100-mm dish). Transfected COS-7 cells were incu-
bated for a 2-h pulse followed by a 40-h chase. In the case of co-culture
experiments, 2  105 cells were plated in 100-mm dishes and trans-
fected with pcDNA1-MmNEU3 or pcDNA1 vector alone, and 3  105
COS-7 were separately subjected to a 2-h pulse with [1-3H]sphingosine.
After labeling, cells were detached from dishes using 0.25% trypsin-
EDTA, resuspended in 10% fetal bovine serum DMEM, and finally
added to plates containing just transfected COS-7 cells. Cells were then
co-cultured for 48 h, resulting in 48 h of post-transfection time and 60 h
of chase. A time course analysis of metabolically labeled [1-3H]sphin-
golipids was performed after adding freshly [1-3H]sphingosine-labeled
COS-7 cells to MmNEU3-HA and mock-transfected cells after 48 h of
post-transfection time. Cells were co-cultured for up to 30 h, corre-
sponding to 78 h post-transfection time and 72 h of chase. Cells were
harvested by scraping, washed in PBS, snap-frozen, lyophilized, and
subjected to lipid extraction and sphingolipid analyses, together with
the dialyzed medium collected from the cell cultures.
Immunofluorescence Staining and Confocal Analysis of MmNEU3—
COS-7 cells were plated onto glass coverslips and grown for 24 h before
transfection. Cells were transfected as previously described. After 16 h
of incubation in DMEM in the presence of 10% fetal bovine serum, cells
were washed in PBS, fixed for 40 min in 3% paraformaldehyde in PBS,
and quenched for 10 min with 50 mM NH4Cl in PBS. For permeabili-
zation, cells were incubated for 15 min in the presence of 0.5% saponin
(w/v) in PBS. Cells were then incubated with anti-HA mouse mono-
clonal antibody 12CA5 (15 g/ml) (Roche Applied Science) in 0.5%
saponin in PBS for 1 h and, after extensive washes with the same
buffer, incubated with donkey anti-mouse Cy2 (1:400) in the same
buffer. Fluorescence microscopy was carried out using an MRC-1024
confocal imaging system (Bio-Rad Laboratories). Image processing was
performed with Adobe Photoshop software.
Treatment of Cell Cultures with [3-3H(Sph18)]GD1a—[3-3H(Sph18)]-
GD1a dissolved in propanol/water, 4:1 (v/v), was transferred into a
sterile glass tube and dried under a nitrogen stream. The residue was
then dissolved in an appropriate volume of pre-warmed (37 °C) DMEM
to obtain [3-3H(Sph18)]GD1a at a final molar concentration of 3  107
M (corresponding to 2 nmol of GD1a/100-mm dish). Transfected COS-7
cells were incubated for up to 24 h in the presence of 10 mM NH4Cl.
Cells were harvested by scraping and washed in PBS, and total lipids
were extracted from the cells and media (data not shown) and analyzed.
Lipid Extraction and Analyses—Total lipids from lyophilized cells
and lyophilized cell media were extracted twice with chloroform/meth-
anol 2:1 (v/v) and with chloroform/methanol/water 20:10:1 (v/v), respec-
tively (37). The resulting lipid extracts were dried under a nitrogen
stream and dissolved in chloroform/methanol 2:1 (v/v). In some exper-
iments the lipid extracts were treated with 0.5 M NaOH in methanol to
remove glycerophospholipids by selective hydrolysis (38). Lipid extracts
were analyzed by HPTLC carried out with the solvent system chloro-
form-methanol-0.2% aqueous CaCl2 50:42:11 (v/v). The total lipid ex-
tracts were subjected to a two-phase partitioning in chloroform-meth-
anol-water, 2:1 (v/v), and 20% water (38); the aqueous and organic
phases obtained were counted for radioactivity and analyzed by
HPTLC. [3H]Sphingolipids of aqueous and organic phases, respectively,
were separated by HPTLC using the solvent systems chloroform-meth-
anol-0.2% aqueous CaCl2, 60:40:9 (v/v), and chloroform-methanol-wa-
ter, 55:20:3 (v/v), respectively. [3H]Sphingolipids were identified by
referring to radiolabeled standards and quantified by radiochromato-
imaging (Beta-Imager 2000, Biospace, Paris, France).
3 NEU is the official human gene symbol approved by HUGO Gene
Nomenclature Committee. To avoid misinterpretation, the NEU symbol
indicates the gene product (that is, sialidase), NEU3 is the symbol for
plasma membrane-associated sialidase, and the two-letter code preced-
ing NEU3 indicates the species of origin (e.g. Mm indicates Mus mus-
culus). The NEU3 mRNA sequence is available in the GenBankTM data
base under accession number NM_016720.
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The structural characterization of the ganglioside mixture from
COS-7 cells was determined by reversed phase HPLC-ESI mass spec-
trometry. ESI mass spectrometry of the ganglioside species was carried
out in negative mode on a ThermoQuest Finnigan LCQdeca mass spec-
trometer equipped with an electrospray ion source (39).
Sialidase Assay—The enzymatic activity of MmNEU3 in total cell
lysates and in cellular subfractions was determined as described pre-
viously using ganglioside [3-3H(Sph18)]GD1a and 4-MU-NeuAc as sub-
strates (40). Assays were performed in triplicate with 25 g of total
protein in a final volume of 100 l and in the presence of 12.5 mM
sodium-citrate/phosphate buffer, pH 3.8. One unit of sialidase activity
is defined as liberation of 1 mol of Neu5Ac/min at 37 °C.
Statistical Analyses—Values are presented as means  S.D. Statis-
tical analyses were made using unpaired Student’s t test. Significance
was attributed at the 95% level of confidence (p  0.05).
RESULTS
MmNEU3 Activity and Structure of Gangliosides in COS-7
Cells—Sialidase activity assay performed at pH 3.8 on GD1a
ganglioside, without detergent in the reaction mixture, conclu-
sively allows determination of the plasma membrane-associ-
ated sialidase activity with very minor or no contamination by
lysosomal enzyme(s) activity (41). Under these experimental
conditions, MmNEU3 activity on GD1a ranged from 0.1 to 0.3
milliunits/mg cell protein. The ganglioside mixture from COS-7
cells was analyzed by HPLC-ESI mass spectrometry, and the
percentage of each species was determined by densitometry
and radioimaging (see below) after HPTLC separation. GD1a,
GM1, GM2, and GM3 were the main gangliosides and repre-
sented 41.8, 31.5, 15.8, and 10.9% of the total main ganglioside
mixture, respectively. Each ganglioside species contained C18
sphingosine and by HPTLC analysis was split in two spots. The
molecular species containing palmitic acid showed a lower mo-
bility, whereas molecular species containing C24:0 and C24:1
fatty acids showed a slightly higher mobility in our solvent
system.
Transient Overexpression of Membrane-bound MmNEU3 in
COS-7 Cells—In this study a tagged form of MmNEU3 was
used (36, 42). The recombinant vector pcDNA1-MmNEU3 al-
FIG. 1. MmNEU3 expression in COS-7 cells. A, COS-7 cells transfected overnight with pcDNA1 vector alone (C) or pDNAI-MmNEU3
construct (NEU3) were grown for 48 h, and sialidase-specific activities toward the substrate 4-MU-NeuAc (white columns) and ganglioside GD1a
(gray columns) were determined in the total cell lysate. Variations in the observed activity are indicated by the error bar (n  3). B, rate of
hydrolysis of ganglioside [3-3H(Sph18)]GD1a over the pH range of 2.8 to 8.0 in 12.5 mM sodium citrate/phosphate buffer using aliquots of the crude
cell homogenate of pcDNA1-MmNEU3-transfected cells (Œ) and pcDNA1 mock-transfected cells () as the enzymatic source. C, sialidase activity
of the supernatant (SN) and pellet (P) obtained by ultracentrifugation at 200,000  g of the total lysate of pcDNA1-MmNEU3-transfected cells.
The rates of hydrolysis of 4-MU-NeuAc were expressed as a percentage of the value detectable in the total cell lysate (n  3). D, Western blot
analysis of protein samples (10 g) obtained by cells transfected with pcDNA1-MmNEU3 (NEU3) and mock-transfected cells (C). Total homogenate
(T), supernatant (S), and pellet (P) obtained by ultracentrifugation were analyzed. The blot was carried out using anti-HA monoclonal antibody.
Detection of antibodies bound to HA epitope was carried out using peroxidase-conjugated isotype-specific antibodies followed by ECL developing
reagents. Protein standard positions (in kDa) are shown on the left.
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lowed the expression in mammalian cells of MmNEU3 as a
chimera protein characterized by the HA epitope linked at the
C terminus of the original open reading frame. This protein can
be detected easily using antibodies against the HA epitope, and
in addition, MmNEU3 retains its original enzyme activity.
Upon transfection MmNEU3 activity increased in a time-de-
pendent manner up to 48 h and remained quite stable until
60 h after transfection. Starting from this time point, the en-
zyme specific activity gradually decreased and disappeared
almost completely at about 72 h post-transfection time (data
not shown).
Sixty hours after transfection, COS-7 cells showed an 11-
and 35-fold increase in sialidase activity ex vivo toward 4-MU-
Neu5Ac and ganglioside GD1a, respectively, as compared with
mock-transfected cells (Fig. 1A). The pH curve showed an op-
timal value in the acidic range corresponding to 3.8, the same
value observed in the case of the endogenous plasma mem-
brane-associate sialidase (Fig. 1B). More than 96% of the
expressed sialidase activity in the crude homogenates was re-
covered in the rough particulate fraction obtained by ultracen-
trifugation (Fig. 1C). The membrane association of MmNEU3
was confirmed by Western blot analysis using an anti-HA
monoclonal antibody. Fig. 1D shows the staining of a protein
band with the expected molecular mass of 48 kDa in the trans-
fected cells, the protein being associated to the 200,000  g cell
pellet. Additional protein bands of 80 and 44 kDa were detected
by the monoclonal antibody. The presence of the same bands in
the cell fractions obtained from mock-transfected cells indi-
cated that they were unrelated to MmNEU3.
To confirm the association with the plasma membrane,
COS-7 cells transiently transfected with expression plasmid
pcDNA1-MmNEU3 were analyzed by confocal microscopy. Fig.
2 shows a cell surface staining in distinct confocal planes of the
same cell expressing the enzyme, with negligible labeling in the
intracellular membranous structures. Based on the ratios be-
tween MmNEU3-expressing cells and their total number, de-
termined by fluorescence microscopy, the average yield of
transfection corresponded to about 20–30%.
Direct administration into the culture media of [3-3H(S-
ph18)]GD1a to mock- and pcDNA1-MmNEU3-transfected
COS-7 cells led to its incorporation into the cell membranes.
Under these conditions, because of the slow ganglioside
turnover, only a minor portion of the radioactive GD1a reaches
the lysosomes and is catabolized (43). COS-7 cells expressing
MmNEU3 showed the conversion of GD1a to the corresponding
GM1 in the presence of NH4Cl, a condition in which the activity
of the lysosomal compartment is strongly reduced (Fig. 3) (44).
Overall, these results confirm the plasma membrane topology
of MmNEU3.
MmNEU3 Activity in Living Cells—Administration of
[1-3H]sphingosine to cultured cells at 3  108 M final concen-
tration led to an extensive labeling of the sphingolipids, namely
gangliosides, neutral glycosphingolipids, sphingomyelin, and
ceramide (43). In addition, a portion of the [1-3H]sphingosine
was catabolized by the cells to radioactive ethanolamine and
then recycled for the biosynthesis of radioactive phosphati-
dylethanolamine. After a 2-h pulse with [1-3H]sphingosine fol-
lowed by a 24-h chase, free sphingosine was scarcely detectable
within the radioactive lipid mixtures, and stable radioactive
lipid patterns overlapping the endogenous one were observed
in mock-transfected cells (Fig. 4, A and B, lane 1). Instead, the
FIG. 2. Immunofluorescence detection of MmNEU3 in COS-7
cells. COS-7 cells grown on glass coverslips were transfected with
pcDNA1-MmNEU3 and after 16 h were processed for indirect immu-
nofluorescence using mouse anti-HA as primary antibodies. Specimens
were analyzed using a MRC-1024 confocal laser system (Bio-Rad), and
images were processed with Adobe Photoshop software. Magnification,
250.
FIG. 3. GD1a hydrolysis in mock- and pcDNA1-MmNEU3-
transfected cells. [3-3H(Sph18)]GD1a was administered directly to
COS-7 cells (2 nmol of GD1a/100-mm dish). Cells were incubated for up
to 24 h in presence of 10 mM NH4Cl, harvested by scraping, and washed
with PBS, and total lipids were extracted from cells and analyzed.
Solvent system chloroform-methanol-0.2% aqueous CaCl2 60:40:9 (v/v).
Lane 1, mock-transfected cells; lane 2, MmNEU3-transfected cells;
lanes 3 and 4, standard radiolabeled GM1 and GD1a, respectively.
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sphingolipid pattern from MmNEU3-expressing cells showed a
marked variation (Fig. 4A, lane 2). In fact, 60 h after transfec-
tion, a 34 and 35% decrease of ganglioside GD1a and GM3
relative contents, respectively, and a 36% increase of ganglio-
side GM1 content were detectable (Fig. 4C). No statistically
significant differences were observed between the radioactive
lipid patterns of organic phases from normal and transfected
cells (Fig. 4B, lanes 1 and 2).
To investigate the possible activity of MmNeu3 toward gan-
glioside substrates exposed on the cell surface of adjacent cells,
a co-culture experiment was engineered by co-culturing
MmNEU3-expressing COS-7 cells with previously [1-3H]sphin-
gosine-labeled untransfected cells. As we envisioned, the mod-
ification of the ganglioside relative abundance followed the
variations of MmNEU3 specific activity induced by transient
expression of the enzyme. In fact, the ganglioside content mod-
ification reached a maximum at 60 h after transfection and
than slowly returned to the endogenous value (Fig. 5A). Fig. 5B
shows the radioactive ganglioside distribution from co-culture
experiments at 60 h after transfection. The ganglioside pattern
is very similar to that observed in [1-3H]sphingosine-labeled
MmNEU3-transfected cells. Overall, these results indicate that
the plasma membrane sialidase activity is exerted mainly to-
ward gangliosides inserted in the membrane of neighboring
cells. Moreover, we found only small amounts of radioactivity
in the cell media. In fact, the metabolically labeled lipids found
in the media amounted to about 2% of the total radiolabeled
ones detectable in the cell lipid extracts. By HPTLC analysis
we found that about 90% of this negligible radioactivity was
due to sphingomyelin.
DISCUSSION
As already reported in the case of its human counterpart
(45), mouse MmNEU3 was demonstrated to be a membrane-
associated enzyme with an optimum pH in the acid range (pH
3.8) when measured using classical ex vivo assays. Confocal
microscopy of COS-7 cells expressing MmNEU3 showed an
extensive labeling of the cell surface with a negligible intracel-
lular content of the enzyme. To further confirm the plasma
membrane association of MmNEU3 and its possible activity at
the cell surface, we embedded the plasma membrane with
GD1a and followed its hydrolysis to GM1. Conversion of GD1a
to GM1 occurred without the involvement of the lysosomal
compartment as demonstrated by the fact that the hydrolysis
process was not affected by NH4Cl treatment, a condition that
strongly reduces lysosomal activity.
Moreover, MmNEU3 is an enzyme that is active toward
gangliosides inserted in the plasma membrane of living cells.
In fact, cells expressing MmNEU3 and metabolically labeled
with [1-3H]sphingosine showed a marked decrease of GD1a and
GM3 and an increase of GM1 in comparison with mock-trans-
fected cells. Similar variations of ganglioside relative contents
FIG. 4. Ganglioside pattern in COS-7 cells and effect of
MmNEU3 overexpression on ganglioside contents. Cells (3  105)
were pulsed for 2 h with [1-3H]sphingosine, 3  108 M final concen-
tration. After a 40-h chase, cells were harvested and treated for lipid
analysis (see “Experimental Procedures”). A, HPTLC separation of the
aqueous phase. Solvent system chloroform-methanol-0.2% aqueous
CaCl2 60:40:9 (v/v). Lane 1, mock-transfected cells; lane 2,
pcDNA1-MmNEU3-transfected cells. B, HPTLC separation of the or-
ganic phase obtained by lipid extraction and fractionation. Solvent
system chloroform-methanol-H2O 55:20:3 (v/v). Lane 1, mock-trans-
fected cells; lane 2, pcDNA1-NEU3-transfected cells. C, ganglioside
relative contents observed after a 40-h chase in mock (C)- and
pcDNA1-MmNEU3 (NEU3)-transfected cells. Data are the means 
S.D. of four different experiments carried out in triplicate. Significance
according to Student’s t test: **, p  0.001.
FIG. 5. Co-cultured experiments with pcDNA1-NEU3-
transfected cells in the presence of [1-3H]sphingosine-labeled
untransfected COS-7 cells. Cells (2  105) transfected with
pcDNA1-MmNEU3 or pcDNA1 vector alone were plated in 100-mm
dishes. Meanwhile, (3  105) cells were separately subjected to a 2-h
pulse with [1-3H]sphingosine. After labeling, cells were detached from
dishes and added to plates containing the previously transfected COS-7
cells. At different time, cells were harvested and treated for lipid anal-
ysis as described previously. A, time course analysis of metabolically of
ganglioside relative content up to 78 h post-transfection. B, ganglioside
content of mock (C)- and pcDNA1-MmNEU3 (NEU3)-transfected cells.
Data are the means  S.D. of three different experiments carried out in
triplicate. Significance according to Student’s t test: *, p  0.05.
MmNEU3 Acts on Gangliosides of Neighboring Cells 16993
were detectable when sialidase substrates were represented by
metabolic radiolabeled gangliosides at the cell surface of un-
transfected cells (see co-culture experiments). In addition, the
modification of the ganglioside pattern was reversible and
strictly dependent on MmNEU3 transient expression. Further-
more, the finding of a negligible amount of radiolabeled lipids
in the culture media excludes significant ganglioside shedding
(46) under our experimental conditions. Therefore, the discov-
ery that MmNEU3 is able to modify the ganglioside content of
neighboring cells supports MmNEU3 involvement in cell-to-
cell interaction, implications that are still unclear but are wor-
thy of further studies. The ability of plasma membrane-associ-
ated sialidase to recognize a substrate that is not part of the
same cell plasma membrane in which it resides was suggested
some time ago by studies done on cell adhesion (47, 48) and,
more recently, by studies on a GD1a ganglioside derivative
covalently linked to bovine serum albumin (49).
The capability of MmNEU3 to work through cell-to-cell in-
teractions could be predicted by looking at the three-dimen-
sional structures of the sialidase enzyme available thus far.
Actually, mammalian sialidases show a high degree of amino
acid sequence homology and share highly conserved amino acid
motifs throughout the evolutionary scale from viral neuramin-
idase to bacterial enzymes (26, 50). In addition, all of the
microbic sialidases structures available thus far show a typical
-propeller (or barrel) structure, with the active site located in
a shallow crevice on the top of the barrel containing roughly a
dozen of highly conserved amino acids (51). Most of these
residues are present in topologically equivalent positions in all
of the mammalian sialidases cloned thus far, strongly suggest-
ing that the enzymes exist in a similar three-dimensional
structure. In addition, MmNEU3 does not show either multiple
stretches of hydrophobic amino acids or potential glycosylphos-
phatidylinositol modification or palmitoylation or myristoyla-
tion sites along the primary structure, thus rendering rather
puzzling the issue of its anchorage to the plasma membrane.
From this perspective, the presence of short hydrophobic amino
acid stretches at the C terminus of the protein could suggest
their involvement in the membrane association of MmNEU3 as
a tail-anchored protein (52, 53). The structures of HsNEU1 (54)
and HsNEU2 (55) carried out using computer modeling ap-
proaches, positioned the C-terminal portion of the molecule on
the opposite site of the catalytic crevice. Thus, based on the
assumption of a common three-dimensional structure of siali-
dases, the MmNEU3 barrel could stand on the lipid bilayer
with the active site toward the extracellular space, far away
from the oligosaccharide chains of the sphingolipids inserted in
the outer leaflet of the membrane. For example, the terminal
Gal-Neu5Ac linkage of GD1a, which is hydrolyzed by
MmNEU3, should be about 20 Å away from the membrane
surface (56–58), whereas the enzyme active site on the top of
the barrel is located about 50 Å from the surface of the cell (55).
Evidently, our results do not exclude the possibility that an
enzyme activity can occur toward gangliosides of the same
membrane, assuming that the barrel is able to lie down on the
membrane surface, and/or in area of the cell surface where the
plasma membrane is sharply bent, allowing the exposition of
the substrate oligosaccharide chains directly to MmNEU3 ac-
tive site. In fact, NEU3 activity toward self-membrane sub-
strate has been suggested to occur in diluted cultures of neu-
roblastoma cell lines (36, 59) as well as in hippocampal neurons
(42).
The finding that MmNEU3 is able to recognize and hydro-
lyze gangliosides belonging to neighboring cells is very attrac-
tive. In fact, both MmNEU3 (28) and gangliosides are segre-
gated, together with cholesterol and the other sphingolipids, in
SED or lipid rafts (2). From this perspective, MmNEU3 activity
might modify the ganglioside relative content within SED and
thus participate in important functional membrane events
such as signal transmission, cell adhesion, and lipid/protein
sorting (60).
Overall, MmNEU3 activity seems to be an important factor
in the modulation of the cell surface ganglioside pattern di-
rectly in situ without the intervention of the lysosomal com-
partment. Such a surface plasticity could be very important for
cell adaptation to altered environmental conditions. Experi-
ments aimed at better characterizing the effects exerted by
MmNEU3 on the ganglioside composition lipid raft could pro-
vide new insight into sialidase biology, leading toward a com-
prehensive picture of the ganglioside roles within the lipid rafts
and, more generally, on the cell surface.
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